 |
Adam Bonislawski is the editor of GenomeWeb's ProteoMonitor. He covers proteomics and life science mass spectrometry. E-mail Adam Bonislawski and follow his GenomeWeb Twitter account at @ProteoMonitor. |
Somalogic Publishes Validation Study on 13-Protein Dx for Detection of Mesothelioma
October 05, 2012
Somalogic Publishes Validation Study on 13-Protein Dx for Detection of Mesothelioma
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- NYU, Somalogic Present Data on Protein Biomarker Test for Mesothelioma
April 8, 2011 / ProteoMonitor - NCI's Early Detection Research Network Running Trials to Compare Biomarker-Based Cancer Diagnostics
April 22, 2011 / ProteoMonitor - Somalogic Launches Validation Studies of Protein Biomarkers for Pancreatic Cancer and Mesothelioma
October 15, 2010 / ProteoMonitor - Somalogic Partners with NEC in Effort to More Broadly Leverage Aptamer-Based Technology
September 10, 2010 / ProteoMonitor - Quest Launches EGFR Test for Erbitux, Vectibix Users Based on Somalogic's Somamer Technology
September 21, 2012 / ProteoMonitor